Tight glycemic control in critically ill adults

JAMA

Volumn 300, Issue 8, 2008, Pages 963-965

  Finfer, Simon ^a,b,c   Delaney, Anthony ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; CRITICALLY ILL PATIENT; DISEASE SEVERITY; EDITORIAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INTENSIVE CARE UNIT; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR;

EID: 50449090609     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.8.963     Document Type: Editorial

References (19)

1. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.
2. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57-65.
3. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(suppl 1):S12-S54.
4. Institute for Healthcare Improvement. Implement effective glucose control: establish a glycemic control policy in your ICU. http://www.ihi.org/ IHI/ Topics/CriticalCare/IntensiveCare/Changes/ImplementEffectiveGlucoseControl. htm. Accessed July 20, 2008.
5. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-944.
6. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature VI: how to use an overview: Evidence-Based Medicine Working Group. JAMA. 1994;272(17):1367-1371.
7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
8. Shulman R, Finney SJ, O'Sullivan C, Glynne PA, Greene R. Tight glycaemic control: a prospective observational study of a computerised decision-supported intensive insulin therapy protocol. Crit Care. 2007;11(4):R75.
9. Morris AH, Orme J, Truwit JD, et al. A replicable method for blood glucose control in critically ill patients. Crit Care Med. 2008;36(6):1787-1795.
10. Chase JG, Shaw GM, Le Compte AJ, et al. Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care. 2008;12(2):R49.
11. Chase JG, Shaw GM. Is there more to glycaemic control than meets the eye? Crit Care. 2007;11(4):160.
12. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.
13. Vogelzang M, van der Horst IC, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004;8(3):R122-R127.
14. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006;105(2):244-252.
15. Ouattara A, Grimaldi A, Riou B. Blood glucose variability: a new paradigm in critical care? Anesthesiology. 2006;105(2):233-234.
16. Critchell CD, Savarese V, Callahan A, Aboud C, Jabbour S, Marik P. Accuracy of bedside capillary blood glucose measurements in critically ill patients. Intensive Care Med. 2007;33(12):2079-2084.
17. Kanji S, Buffie J, Hutton B, et al. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-2785.
18. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151-3159.
19. Mitchell I, Finfer S, Bellomo R, Higlett T; ANZICS Clinical Trials Group. Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study. Intensive Care Med. 2006;32(6):867-874.